Cardiorespiratory and symptomatic variables during maximal and submaximal exercise in men with stable effort angina: a comparison of atenolol and celiprolol

Ray, S.G., McCann, G., Henderson, E., MacFarlane, N., Christie, J., Norrie, J., Ford, I. , Grant, S. and Dargie, H.J. (1994) Cardiorespiratory and symptomatic variables during maximal and submaximal exercise in men with stable effort angina: a comparison of atenolol and celiprolol. European Heart Journal, 15(11), pp. 1566-1570. (doi:10.1093/oxfordjournals.eurheartj.a060431) (PMID:7835373)

Ray, S.G., McCann, G., Henderson, E., MacFarlane, N., Christie, J., Norrie, J., Ford, I. , Grant, S. and Dargie, H.J. (1994) Cardiorespiratory and symptomatic variables during maximal and submaximal exercise in men with stable effort angina: a comparison of atenolol and celiprolol. European Heart Journal, 15(11), pp. 1566-1570. (doi:10.1093/oxfordjournals.eurheartj.a060431) (PMID:7835373)

Full text not currently available from Enlighten.

Abstract

Celiprolol is a novel beta1 selective adrenoreceptor blocker with partial beta2 agonism and direct vasodilator activity. These ancillary properties may reduce symptomatic breathlessness and fatigue and modify respiration during exercise. To test this hypothesis 20 men with stable effort angina were enrolled in a double-blind crossover study to investigate the effects of atenolol 100 mg once daily (A) and celiprolol 400 mg once daily (C) on cardiorespiratory and symptomatic variables during maximal and submaximal exercise. Total exercise time on a modified Bruce protocol was similar on both treatments: C 12.5 min, A 13.1 min. During steady state submaximal exercise at 60.75% (mean 68%) of maximum work capacity, minute ventilation (C 33.81 min−1, A 33.51 min−1), oxygen uptake (C 14.6 ml.kg−1. min−1, A 151 ml. kg−1. min−1), respiratory exchange ratio (C0.89, A 0.87), ratio of VEI VCO2 (C33.6, A 33.4), ratio of VEIVO2 (C2.34, A 2.72), Borg perceived exertion score (C 11.2, A 10.9) and visual analogue scores for breathlessness (C 29.5, A 25.9) and muscle fatigue (C 28.9, A 26.0) were all similar on both treatments. At maximal exercise capacity on the modified Bruce protocol, minute ventilation (C 58.31 min−1, A 60.41 min−1), oxygen uptake (C 21.3 ml. kg−1. min−1, A 21.7ml. kg−1.min−1), respiratory exchange ratio (C 1.02, A.1.05), ratio VEIVCO2 (C 34.8, A 35.9), and ratio VEIVO2 (C2.80, A 2.83) were also similar on both drugs. Over a 10 day period anginal attacks (C 10.1 ± 10.4, A 5.4 ± 5.9) and sublingual GTN use (C 5.9 ± 10.3, A 4.4 ± 9.8) were both more frequent on celiprolol. We conclude, that in comparison with atenolol, celiprolol did not modify respiration during either steady state submaximal or maximal exercise and did not alleviate symptomatic breathlessness and fatigue. However, symptomatic ischaemia was more frequent with celiprolol.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:MacFarlane, Professor Niall and Ford, Professor Ian
Authors: Ray, S.G., McCann, G., Henderson, E., MacFarlane, N., Christie, J., Norrie, J., Ford, I., Grant, S., and Dargie, H.J.
College/School:College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > Robertson Centre
College of Medical Veterinary and Life Sciences > School of Life Sciences
Journal Name:European Heart Journal
Publisher:Oxford University Press
ISSN:0195-668X
ISSN (Online):1522-9645

University Staff: Request a correction | Enlighten Editors: Update this record